Skandinaviska Enskilda Banken (SEB)’s Relmada Therapeutics RLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-19,984
Closed -$740K 903
2022
Q3
$740K Hold
19,984
0.01% 720
2022
Q2
$379K Buy
+19,984
New +$379K ﹤0.01% 842